Rise and Fall of Therapeutic Hypothermia in Low-Resource Settings: Lessons from the HELIX Trial: Correspondence (original) (raw)

Indian Journal of Pediatrics, 2021

Abstract

To the Editor: We read with interest the review article published online regarding therapeutic hypothermia by Dr Krishnan et al. [1]. We would like to highlight that India has a high rate of perinatal asphyxia, and therapeutic hypothermia (TH) is the only best available evidence-based specific therapy. India is a vast country, known for its heterogeneity not only in the population characteristics but also in the medical care. Many researches done in India are published in high impact factor journals. With all this we would like to highlight certain concerns from the cited article and its implications.

prakash amboiram hasn't uploaded this paper.

Let prakash know you want this paper to be uploaded.

Ask for this paper to be uploaded.